Dentists in Carpentersville, IL Accepting Medicare
9 Dentists found. Showing 1 - 9
 Dr. Gerald Lee Hirsch, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 96 N Kennedy Dr Ste 205, Carpentersville, IL 60110 Phone: 847-426-3402 Fax: 847-426-3473 |
Dr. Christopher J Tabor, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 200 W Main St, Carpentersville, IL 60110 Phone: 847-428-5040 |
Dr. Stanley Joseph Matusik, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 200 West Main, Carpentersville, IL 60110 Phone: 847-428-5040 |
Dr. Chris Lee Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 150 S Kennedy Dr, Suite 23a, Carpentersville, IL 60110 Phone: 847-551-1199 |
Dr. Kory Alyn Waid, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2158 Randall Rd, Carpentersville, IL 60110 Phone: 847-426-9432 |
Dr. Jabal Patel, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2158 Randall Rd, Carpentersville, IL 60110 Phone: 847-426-9430 Fax: 847-426-9439 |
Dr. Songchin Yu, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 150 S Kennedy Dr, 23a, Carpentersville, IL 60110 Phone: 847-551-1199 Fax: 847-783-5282 |
Dr. Daniele Adamo, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2261 Randall Rd, Carpentersville, IL 60110 Phone: 224-484-8221 |
Corey J Walther, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 2323 Randall Rd, Carpentersville, IL 60110 Phone: 847-426-6520 Fax: 847-426-6528 |
News Archive
NICE publishes Medtech Innovation Briefing on ZedScan
The NICE MIB has been developed on ZedScan as an adjunct to colposcopy in women with suspected cervical intra-epithelial neoplasia.
Study assesses effectiveness of UK-wide screening programme for Lynch Syndrome
Screening families of patients with bowel cancer for a genetic condition would cut their risk of developing bowel, womb, and ovarian cancers, new research has found.
Triphase's marizomib receives FDA orphan drug designation for treatment of multiple myeloma
Triphase Accelerator Corporation today announced that marizomib, its novel, potent proteasome inhibitor, has been granted orphan drug designation by the U.S. Food and Drug Administration's Office of Orphan Products Development for the treatment of multiple myeloma. The orphan drug designation will provide Triphase with 7-year marketing exclusivity for marizomib and other benefits upon FDA approval.
Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients
In a study by researchers explored the possible mechanisms of the clotting disorder, focusing on the role of hypoxia-related activation of coagulation factors; cytokine storm, activation of neutrophils, and the release of neutrophil extracellular traps.
› Verified 5 days ago
Pharmacists
Dentists
Counselors
Clinical Social Workers
Occupational Therapists